(Q37801097)

23 August 2017

title

Alcoholic steatohepatitis (English)

1 reference

23 August 2017

0 references

alcoholic fatty liver

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20955970

5 August 2024

author name string

Felix Stickel

1

1 reference

23 August 2017

Helmut K. Seitz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20955970

5 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20955970

5 August 2024

publication date

1 October 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S152169181000082X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

https://api.elsevier.com/content/article/PII:S152169181000082X?httpAccept=text/plain

5 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Best Practice and Research: Clinical Gastroenterology

5 August 2024

published in

1 reference

23 August 2017

volume

24

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

683-693

1 reference

Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Molecular mechanisms of alcohol-mediated carcinogenesis

5 August 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group

5 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Excess weight risk factor for alcoholic liver disease

5 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Influence of liver biopsy on abstinence in alcohol-dependent patients

5 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis

5 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Interobserver agreement in the physical diagnosis of alcoholic liver disease

5 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Accuracy of clinical diagnosis of cirrhosis among alcohol-abusing men.

5 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Alcohol drinking and risk of hospitalization for heart failure with and without associated coronary artery disease

5 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Relationship between ethanol-related diseases and nutritional status in chronically alcoholic men

5 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Nutritional deficiencies in chronic alcoholics: relation to dietary intake and alcohol consumption

5 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

ALCOHOL: its metabolism and interaction with nutrients

5 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

THE OCCURRENCE OF ABNORMAL DARK ADAPTATION AND ITS RELATION TO VITAMIN A METABOLISM IN PATIENTS WITH CIRRHOSIS OF THE LIVER.

5 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking

5 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Effect of chronic alcohol consumption on total plasma homocysteine level in rats

5 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Bacterial infection in cirrhotic patients and its relationship with alcohol

5 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

5 August 2024

Alcoholic liver disease.

18

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Pathological spectrum of alcoholic liver disease

5 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis

5 August 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis

5 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone

5 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

MELD accurately predicts mortality in patients with alcoholic hepatitis

5 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis

5 August 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score

5 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.

5 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

5 August 2024

Alcoholic hepatitis

28

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Increased plasma tumor necrosis factor in severe alcoholic hepatitis

5 August 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.

5 August 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Higher neutrophil infiltration mediated by osteopontin is a likely contributing factor to the increased susceptibility of females to alcoholic liver disease

5 August 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Intrahepatic gene expression in human alcoholic hepatitis.

5 August 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress

5 August 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

New concepts in the pathogenesis of alcoholic liver disease

5 August 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase

5 August 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice

5 August 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis

5 August 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease

5 August 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans

5 August 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole

5 August 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

II. Veterans Affairs Cooperative Study of Polyenylphosphatidylcholine in Alcoholic Liver Disease

5 August 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.

5 August 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial

5 August 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Homocysteine, the bad thiol

5 August 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice

5 August 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Rifaximin treatment in hepatic encephalopathy

5 August 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies

5 August 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

The effects of alcohol use on rebleeding and mortality in patients with alcoholic cirrhosis following variceal haemorrhage

5 August 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial

5 August 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

VA Cooperative Study on Alcoholic Hepatitis. III: Changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy

5 August 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis

5 August 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Hyperalimentation in alcoholic hepatitis

5 August 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Metabolic effects of enteral formula feeding in alcoholic hepatitis

5 August 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study

5 August 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Review article: Nutritional therapy in alcoholic liver disease

5 August 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone

5 August 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial

5 August 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

A randomized trial of prednisolone in patients with severe alcoholic hepatitis

5 August 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Systematic review: glucocorticosteroids for alcoholic hepatitis--a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials

5 August 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.

5 August 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study

5 August 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.

5 August 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis.

5 August 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis

5 August 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.

5 August 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis

5 August 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis

5 August 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry).

5 August 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases

5 August 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

Recommendations for alcohol-related liver disease

5 August 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation

5 August 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2010.07.003

5 August 2024

Identifiers

1 reference

23 August 2017

1 reference